Your browser is no longer supported. Please, upgrade your browser.
AGRX Agile Therapeutics, Inc. daily Stock Chart
Agile Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own0.80% Shs Outstand76.65M Perf Week-8.54%
Market Cap222.59M Forward P/E- EPS next Y-0.31 Insider Trans- Shs Float67.07M Perf Month-8.21%
Income-21.80M PEG- EPS next Q-0.14 Inst Own38.50% Short Float4.37% Perf Quarter35.26%
Sales- P/S- EPS this Y34.70% Inst Trans20.22% Short Ratio1.31 Perf Half Y-11.99%
Book/sh1.18 P/B2.18 EPS next Y49.20% ROA-40.20% Target Price- Perf Year72.48%
Cash/sh1.08 P/C2.37 EPS next 5Y- ROE-45.60% 52W Range0.35 - 4.77 Perf YTD2.80%
Dividend- P/FCF- EPS past 5Y23.20% ROI- 52W High-46.07% Beta1.47
Dividend %- Quick Ratio33.70 Sales past 5Y- Gross Margin- 52W Low634.29% ATR0.16
Employees15 Current Ratio33.70 Sales Q/Q- Oper. Margin- RSI (14)39.25 Volatility5.02% 6.02%
OptionableYes Debt/Eq0.00 EPS Q/Q17.80% Profit Margin- Rel Volume0.74 Prev Close2.74
ShortableYes LT Debt/Eq0.17 EarningsMay 05 AMC Payout- Avg Volume2.24M Price2.57
Recom1.60 SMA20-8.85% SMA50-7.80% SMA2008.63% Volume1,689,520 Change-6.20%
Apr-12-19Resumed Janney Buy $4
Nov-29-18Initiated Maxim Group Buy $3
Dec-26-17Downgrade William Blair Outperform → Mkt Perform
Dec-26-17Downgrade Janney Buy → Neutral
Oct-02-17Resumed H.C. Wainwright Buy $10
Sep-14-17Reiterated RBC Capital Mkts Outperform $8 → $10
Jul-19-17Initiated H.C. Wainwright Buy $10
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Jun-17-14Initiated William Blair Outperform
Jun-17-14Initiated RBC Capital Mkts Outperform $12
Jul-01-20 01:22AM  
Jun-23-20 08:30AM  
Jun-16-20 08:00AM  
Jun-10-20 09:35AM  
May-28-20 12:37PM  
May-11-20 04:05PM  
May-07-20 08:36AM  
May-05-20 04:01PM  
May-04-20 12:07PM  
Apr-23-20 07:30AM  
Apr-22-20 08:00AM  
Apr-01-20 05:50PM  
Mar-23-20 04:31PM  
Mar-18-20 08:49AM  
Mar-15-20 04:02PM  
Mar-03-20 03:00PM  
Feb-25-20 11:41AM  
Feb-21-20 12:00PM  
Feb-20-20 04:14PM  
Feb-14-20 06:46PM  
Feb-12-20 09:18AM  
Feb-11-20 08:46AM  
Feb-10-20 04:30PM  
Feb-03-20 01:30PM  
Jan-28-20 01:48PM  
Jan-10-20 09:33AM  
Jan-09-20 06:19AM  
Jan-07-20 10:22AM  
Jan-06-20 08:14AM  
Jan-03-20 07:55AM  
Jan-02-20 08:00AM  
Dec-23-19 08:36AM  
Dec-19-19 04:05PM  
Dec-14-19 06:59PM  
Nov-15-19 10:09AM  
Nov-14-19 04:30PM  
Nov-11-19 04:40PM  
Nov-05-19 06:53AM  
Nov-04-19 11:24AM  
Oct-31-19 01:11PM  
Oct-30-19 06:33PM  
Oct-29-19 05:24PM  
Oct-28-19 08:00AM  
Oct-25-19 09:30AM  
Oct-14-19 12:17AM  
Oct-01-19 09:44AM  
Sep-30-19 11:16PM  
Sep-25-19 08:23AM  
Sep-19-19 10:29AM  
Sep-10-19 09:00AM  
Sep-06-19 07:30AM  
Sep-05-19 10:12AM  
Aug-30-19 09:45AM  
Aug-22-19 10:50AM  
Aug-08-19 04:15PM  
Aug-02-19 09:05AM  
Aug-01-19 04:01PM  
Jul-18-19 07:30AM  
Jun-24-19 04:15PM  
May-22-19 07:00AM  
May-17-19 07:30AM  
May-09-19 08:00AM  
May-03-19 08:00AM  
May-02-19 06:56PM  
Mar-28-19 08:00AM  
Mar-15-19 08:00AM  
Mar-14-19 12:00PM  
Mar-12-19 05:52PM  
Mar-11-19 08:00AM  
Mar-04-19 07:30AM  
Feb-12-19 10:30AM  
Feb-11-19 07:30AM  
Feb-07-19 08:00AM  
Jan-11-19 10:45AM  
Jan-10-19 04:15PM  
Dec-27-18 07:25AM  
Dec-18-18 08:00AM  
Dec-13-18 04:15PM  
Nov-13-18 01:32PM  
Nov-05-18 01:30PM  
Nov-02-18 05:12AM  
Nov-01-18 04:15PM  
Oct-24-18 08:00AM  
Oct-23-18 08:25AM  
Oct-22-18 08:15AM  
Oct-16-18 08:00AM  
Agile Therapeutics, Inc., a women's healthcare company, focuses on the research, development, and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter and lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALTOMARI ALFREDChief Executive OfficerJun 22Option Exercise1.7650,00088,000361,611Jun 23 05:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerMar 13Buy1.751,000,0001,750,00015,919,925Mar 17 03:50 PM
Reilly DennisChief Financial OfficerMar 04Buy2.3525,00058,75025,000Mar 06 08:00 AM
Reilly DennisChief Financial OfficerMar 04Buy2.3250,000116,00059,806Mar 06 08:00 AM
ALTOMARI ALFREDChief Executive OfficerFeb 27Option Exercise0.7116,54111,744301,611Feb 27 09:27 PM
ALTOMARI ALFREDChief Executive OfficerFeb 27Buy2.7110,00027,100311,611Feb 27 09:27 PM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 25Buy3.003,000,0009,000,00014,919,925Feb 25 08:10 PM
PERCEPTIVE ADVISORS LLC10% OwnerNov 15Buy1.685,333,8008,940,81211,919,925Nov 18 07:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerNov 14Buy1.69435,015735,1756,586,125Nov 18 07:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 29Sale0.44760,291334,5286,151,110Oct 31 06:30 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 28Sale0.513,815,3491,945,8286,911,401Oct 30 06:31 PM
PERCEPTIVE ADVISORS LLC10% OwnerAug 06Buy0.952,300,0002,185,00010,726,750Oct 30 06:31 PM